Yatharth Hospital reports strong Q2 FY26 results, PAT up 33%, credit rating upgraded, and MSCI inclusion
Yatharth Hospital's Q2 FY26 PAT rose 33% to ₹41.3 crore on 28% revenue growth. Highlights include a credit rating upgrade, MSCI India Small Cap Index inclusion, and strategic bed capacity expansion.
The strong financial performance, coupled with strategic acquisitions and significant corporate developments like the credit rating upgrade and MSCI inclusion, are likely to have a substantial positive impact on the company's valuation, investor confidence, and future growth trajectory. The expansion of bed capacity and focus on super-specialties further strengthens its market position.
The company reported robust financial growth in Q2 FY26 with significant increases in revenue and PAT. Key positive developments include a credit rating upgrade, inclusion in the MSCI India Small Cap Index, a favorable income tax order, and strategic bed capacity expansion through new acquisitions and facility inaugurations, all indicating strong operational and strategic performance.
* Yatharth Hospital & Trauma Care Services Limited announced its Q2 FY26 consolidated financial results, with revenue from operations growing by 28% year-on-year (YoY) to ₹2,79.4 crore. * Consolidated Profit After Tax (PAT) increased by 33% YoY to ₹41.3 crore, with a PAT margin of 14.8%, up 55 basis points. * Consolidated EBITDA for Q2 FY26 stood at ₹64.5 crore, an 18% YoY increase, achieving a margin of 23.1%. * For H1 FY26, consolidated revenue grew 25% YoY to ₹537.2 crore, and PAT rose 36% YoY to ₹83.3 crore. * Operational highlights for Q2 FY26 include an Average Revenue Per Occupied Bed (ARPOB) of ₹32,015, a 4% YoY increase, and an occupancy rate of 66%, up 6% YoY. * The company strengthened its governance framework with the appointment of MSKA & Associates as statutory auditor at the September 2025 Annual General Meeting and Mr. Ramesh Krishnan as an Independent Director. * Yatharth Hospital received a favorable order on a pending Income Tax matter, leading to the release of provisional attachment of its properties and Fixed Deposits. * CRISIL upgraded the company's credit ratings to CRISIL A/Stable, reflecting an improved business risk profile. * The company was included as a constituent of the MSCI India Small Cap Index, effective August 26, 2025, enhancing its visibility among global investors. * Yatharth Hospital acquired a 100% stake in an Agra hospital for ₹260 crore, adding 150 beds (expandable to 250 beds), which is expected to be integrated in H2 FY26 and contribute meaningfully to revenue and EBITDA. * The Model Town (New Delhi) facility, adding 300 beds, was inaugurated in mid-July 2025, and the Faridabad facility (400 beds) commenced operations at the end of September 2025; both are expected to contribute significantly from Q3 FY26 onwards. * The company continues to focus on enhancing super-specialties, leading to ARPOB growth across its hospitals, with Noida Extension achieving the highest ARPOB of ₹40.8 thousand (+7% YoY).
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.